Search Results - "Souan, Lina"

Enhanced RBD-Specific Antibody Responses and SARS-CoV-2-Relevant T-Cell Activity in Healthcare Workers Following Booster Vaccination by Souan, Lina, Abdel-Razeq, Hikmat, Sughayer, Maher A

“…COVID-19 continues to impact healthcare workers (HCWs), making it crucial to investigate vaccine response rates. This study examined HCWs' humoral and cellular…”
Get full text

Dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among healthy blood donors: The evolution of a pandemic by Sughayer, Maher A., Mansour, Asem, Al Nuirat, Abeer, Souan, Lina, Ghanem, Mohammad, Siag, Mahmoud

“…•Seroprevalence rates of SARS-CoV-2 provide important epidemiological data.•Dramatic rise in seroprevalence rates in blood donors, from 0% to 27.4%.•The…”
Get full text

Comparative Assessment of the Kinetics of Cellular and Humoral Immune Responses to COVID-19 Vaccination in Cancer Patients by Souan, Lina, Abdel-Razeq, Hikmat, Al Zughbieh, Muna, Al Badr, Sara, Sughayer, Maher A

“…The kinetics of immune responses to various SARS-CoV-2 vaccines in cancer patients were investigated. In total, 57 cancer patients who received BNT162b2-RNA or…”
Get full text

Changing trends in seroprevalence rates of transfusion-transmitted diseases among blood donors in Jordan by Souan, Lina, Siag, Mahmoud, Al-Salahat, Hala, Al-Atrash, Tareq, Sughayer, Maher A

“…Hepatitis B and C infections and transmission are a serious challenge to all healthcare systems. We studied seroprevalence rates of Transfusion Transmitted…”
Get full text

Non-Dexamethasone Corticosteroid Therapy's Effect on COVID-19 Prognosis in Cancer Patients: A Retrospective Study by Souan, Lina, Al-Khairy, Zienab, Battah, Abdelkader, Sughayer, Maher A

“…Anti-inflammatory corticosteroids are used in cancer treatment and COVID-19 infections. Data on the impact of non-dexamethasone corticosteroids on COVID-19…”
Get full text

COVID-19 Antibody Seroconversion in Cancer Patients: Impact of Therapy Cessation—A Single-Center Study by Souan, Lina, Abdel-Razeq, Hikmat, Nashwan, Sura, Al Badr, Sara, Alrabi, Kamal, Sughayer, Maher A

“…Background: The effective development of COVID-19 vaccination has mitigated its harm. Using two laboratory methods, we investigated the efficacy of the…”
Get full text

An update on the impact of SARS-CoV-2 pandemic public awareness on cancer patients' COVID-19 vaccine compliance: Outcomes and recommendations by Souan, Lina, Sughayer, Maher A., Abu Alhowr, Maha, Ammar, Khawlah, Bader, Sara Al

“…BackgroundAside from the pandemic's negative health effects, the world was confronted with public confusion since proper communication and favorable decisions…”
Get full text

The Effect of Dexamethasone Treatment on COVID-19 Prognosis in Cancer Patients by Souan, Lina, Al-Khairy, Zienab, Al-Binni, Maysaa' Adnan, Battah, Abdelkader, Sughayer, Maher A

“…Background: Dexamethasone is used to treat cancer, relieve chemotherapy-induced nausea and vomiting, enhance cancer patients’ appetites, and treat COVID-19…”
Get full text

Comparison of the Immunogenicity and Protective Efficacy of Various SARS-CoV-2 Vaccines among Healthcare Workers: Are Our White Coat Armies Protected? by Souan, Lina, Sughayer, Maher A, Abualhour, Maha M, Siag, Mahmoud, Al-Badr, Sara, Al-Atrash, Tareq

“…Background: The effective immunization of healthcare workers (HCWs) plays a vital role in preventing the spread of SARS-CoV-2 infection during the coronavirus…”
Get full text

Complete Freund's adjuvant immunization prolongs survival in experimental prion disease in mice by Tal, Yuval, Souan, Lina, Cohen, Irun R., Meiner, Zeev, Taraboulos, Albert, Mor, Felix

“…We recently reported that immunization of mice with certain self‐prion protein peptides induced specific T‐cell and B‐cell immune responses; importantly, this…”
Get full text

Increase in the 64-kDa subunit of the polyadenylation/cleavage stimulatory factor during the G0 to S phase transition by Martinic, Kathleen, Campbell, Ronna, Edwalds-Gilbert, Gretchen, Souan, Lina

“…The amount of the 64-kDa subunit of polyadenylation/cleavage stimulatory factor (CstF-64) increases 5-fold during the G 0 to S phase transition and concomitant…”
Get full text

QuantiFERON‐CMV and monitor predict cytomegalovirus, mortality, and graft‐versus‐host disease in transplant recipients by Souan, Lina, Jazar, Husam Abu, Nashwan, Sura, Sughayer, Maher A.

“…Cytomegalovirus (CMV) is the most prevalent infection in recipients of hematopoietic stem cell transplant (HSCT). QuantiFERON‐CMV (QF‐CMV) and…”
Get full text

Seroprevalence rates of transfusion-transmitted infections among blood donors in Jordan by Souan, Lina, Tout, Faten, Siag, Mahmoud, Sughayer, Maher A

“…Statistics on the prevalence of donor screening for hepatitis B surface antigen (HBsAg) and anti-hepatitis C virus (anti-HCV) in Jordan are outdated. There are…”
Get full text

Imatinib mesylate inhibits T-cell proliferation in vitro and delayed-type hypersensitivity in vivo by Dietz, Allan B., Souan, Lina, Knutson, Gaylord J., Bulur, Peggy A., Litzow, Mark R., Vuk-Pavlović, Stanimir

“…Imatinib mesylate (STI571, imatinib) inhibited DNA synthesis in primary human T cells stimulated with allogeneic mature dendritic cells or phytohemagglutinin…”
Get full text

Establishing an Iso-Compliant Modern Cancer-Biobank in a Developing Country: A Model for International Cooperation by Sughayer, Maher A, Souan, Lina

“…King Hussein Cancer (KHCC) is a specialized cancer center that treats both adult and pediatric cancer patients from Jordan and the neighboring countries. KHCC…”
Get more information

A KDR-binding peptide (ST100,059) can block angiogenesis, melanoma tumor growth and metastasis in vitro and in vivo by RASTELLI, Luca, VALENTINO, Maria Luisa, GOLDFARB, Ronald H, RABBANI, Shafaat A, CORSO MINDERMAN, Melissa, LANDIN, Judith, MALYANKAR, Uriel M, LESCOE, Mary K, KITSON, Richard, BRUNSON, Kenneth, SOUAN, Lina, FORENZA, Salvatore

“…A major goal of treatment strategies for cancer is the development of agents which can block primary tumor growth and development as well as the progression of…”
Get full text

The establishment of an ISO compliant cancer biobank for Jordan and its neighboring countries through knowledge transfer and training by Barr, Martin, Souan, Lina, MacGabhann, Peadar, Müller, Jeanette, Al Ashhab, Maxim, Jasser, Mohammed, Hamza, Khetam, Al Hassoon, Sallam, Kuhn, Uwe, Infante, Daniela, Lawlor, Denise, Gately, Kathy, Amireh, Eyad, O'Byrne, Kenneth, Sughayer, Maher A

“…Research studies aimed at advancing cancer prevention, diagnosis, and treatment depend on a number of key resources, including a ready supply of high-quality…”
Get more information

Modulation of proteinase‐K resistant prion protein by prion peptide immunization by Souan, Lina, Tal, Yuval, Felling, Yacov, Cohen, Irun R., Taraboulos, Albert, Mor, Felix

“…Prion diseases are caused by conformational alterations in the prion protein (PrP). The immune system has been assumed to be non‐responsive to the self‐prion…”
Get full text

Self Prion Protein Peptides are Immunogenic in Lewis Rats by Souan, Lina, Margalit, Raanan, Brenner, Ori, Cohen, Irun R, Mor, Felix

“…Prion diseases are caused by abnormal folding of the prion protein. The paradigm is that the prion protein is not immunogenic because the immune system must be…”
Get full text

Increase in the 64-kDa subunit of the polyadenylation/cleavage stimulatory factor during the G 0 to S phase transition by Martincic, Kathleen, Campbell, Ronna, Edwalds-Gilbert, Gretchen, Souan, Lina, Lotze, Michael T., Milcarek, Christine

“…The amount of the 64-kDa subunit of polyadenylation/cleavage stimulatory factor (CstF-64) increases 5-fold during the G 0 to S phase transition and concomitant…”
Get full text